More patients at risk of developing liver cancer are receiving potentially life-saving monitoring here at Medway thanks to the introduction of a new digital tracking system.
An internal audit recently revealed that our monitoring rates increased from 67 per cent to 90 per cent after the InfoFlex system was introduced to our Hepatology service in August 2025.
This means more patients are receiving regular checks as part of a liver surveillance programme that can help identify liver cancer at an earlier stage.
Because the system keeps track of adult patients who need monitoring, it ensures appointments are arranged at the right time. For patients, this means greater reassurance that any signs of cancer can be identified as early as possible.
It also means more patients are receiving the regular checks recommended by NHS guidance.
Louise Eales, Hepatology Clinical Nurse Specialist and a member of the team behind the initiative, said: “For patients at increased risk of liver cancer, including those with cirrhosis, advanced liver fibrosis, hepatitis B and hepatitis C, regular monitoring can make a life-changing difference.
“This includes ultrasound scans and blood tests every six months to check for any early signs of cancer.
“Detecting cancer at an earlier stage often means patients have access to more treatment options and a much better chance of successful treatment.
“Our new system helps ensure patients receive the checks they need at the right time, giving them the best possible opportunity for an early diagnosis and access to treatment.”
Dr Jonathan Bryant, Primary Care Clinical Lead for Cancer at the Kent and Medway Cancer Alliance, said: “Earlier detection of liver cancer can save lives.
“By making sure patients receive regular checks at the right time, the team is helping more people get diagnosed earlier, access treatment sooner and improve their chances of a successful outcome.
Read our hospital magazine!
Join us in making a difference
